15.1 C
London
Wednesday, June 7, 2023

Schedule Your Presentation to Thousands of Investors Now

Tag: Pharmaceutical

Emerging Growth Pharmaceutical Companies

Can B Corp Announces Full Year 2020 Results

“As it was for many companies, 2020 was a challenging year for us,” commented Marco Alfonsi, Can B’s Chief Executive Officer. “We took the time to right-size our expenses, focus our energy on higher margin revenue opportunities and improve our positioning for future growth and profits.”

Multicorp (MCIC) Announces Change in Corporate Operations

Multicorp (MCIC) Announces Change in Corporate Operations

CLS Holdings USA, Inc. Announces Amendments to Convertible Debentures and Underlying...

 Miami, FL – March 31, 2021 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled...

CytoDyn (OTCQB: CYDY) Stuns FDA with 400% Improvement in 14 Day...

CytoDyn Inc. (OTCMKTS: CYDY) just released stunning numbers which takes the company down one of two roads.  The first road is a quick review by the FDA...

Cannabis Stocks to Grow Your Stimulus Payment

The writer notes that investors who are more risk-tolerant may find significant gains by investing in select cannabis stocks. Specifically, the article calls out one Canadian and one American cannabis company that may see growth soon.

Major Moves from Cannabis Players Last Week

Recently, CLS Holdings USA, Inc. (OTCQB:CLSH; CSE:CLSH) announced its second quarter results for fiscal 2021, which included a 61% increase in revenue over the second fiscal quarter of 2020. This was driven by a 58% increase in year over year quarterly revenue at City Trees, and continued growth in traffic and average transaction totals at Oasis Cannabis.

Supplier to Cannabis Companies Makes Another Big Acquisition

Meanwhile, the author notes, cannabis stocks including Tilray (NASDAQ:TLRY), Canopy Growth (NASDAQ:CGC), Cronos Group (NASDAQ:CRON), and Aurora Cannabis (NYSE:ACB) had all declined.

AXIM Biotechnologies’ (AXIM) Partner Empowered Diagnostics Files Emergency Use Authorization With...

AXIM Biotechnologies’ (AXIM) Partner Empowered Diagnostics Files Emergency Use Authorization With FDA for Its Rapid COVID-19 Neutralizing Antibody Test

Ancillary Cannabis Companies See Continued Growth

The writer notes that investors are warming up to ancillary cannabis companies that do not directly cultivate or distribute cannabis products. Among these include AFC Gamma (NASDAQ:AFCG), who announced the pricing of its IPO last week.

Halberd Corporation (HALB) Completes Compilation of Medical Articles in Support of...

Halberd Corporation (HALB) Completes Compilation of Medical Articles in Support of Nutraceuticals in Their VITA-SHIELD-MAX Immune Booster